Compare · KMTS vs MMM
KMTS vs MMM
Side-by-side comparison of Kestra Medical Technologies Ltd. (KMTS) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KMTS and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $79.87B, about 64.4x KMTS ($1.24B).
- Over the past year, KMTS is down 5.4% and MMM is up 3.3% - MMM leads by 8.7 points.
- MMM has been more active in the news (24 items in the past 4 weeks vs 1 for KMTS).
- MMM has more recent analyst coverage (25 ratings vs 7 for KMTS).
- Company
- Kestra Medical Technologies Ltd.
- 3M Company
- Price
- $21.24+0.12%
- $153.18+0.22%
- Market cap
- $1.24B
- $79.87B
- 1M return
- +8.64%
- +6.46%
- 1Y return
- -5.43%
- +3.31%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 1
- 24
- Recent ratings
- 7
- 25
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest KMTS
- Officer Webster Brian Daniel sold $314,329 worth of shares (15,000 units at $20.96) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 334,786 units (SEC Form 4)
- Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
- Kestra Showcases Accelerated Innovation at HRS 2026
- SEC Form 4 filed by Webster Brian Daniel
- Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
- Amendment: SEC Form SCHEDULE 13G/A filed by Kestra Medical Technologies Ltd.
- SEC Form S-3ASR filed by Kestra Medical Technologies Ltd.
- SEC Form 4 filed by Cohen Raymond W
- Kestra Medical Technologies Named Finalist for 2026 GeekWire "Deal of the Year"
- SEC Form 4 filed by Webster Brian Daniel
Latest MMM
- SEC Form SD filed by 3M Company
- 3M Announces Upcoming Investor Event
- 3M Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Sweet Thomas W was granted 1,360 shares (SEC Form 4)
- Director Kereere Suzan was granted 1,360 shares, increasing direct ownership by 27% to 6,422 units (SEC Form 4)
- Director Fitterling James R was granted 1,360 shares (SEC Form 4)
- Director Brown Thomas K was granted 1,360 shares (SEC Form 4)
- Director Chow Anne H was granted 1,360 shares (SEC Form 4)
- Director Choi Audrey was granted 1,360 shares (SEC Form 4)
- Director Bozeman David P was granted 1,360 shares (SEC Form 4)